表紙:脳モダリティおよびソフトウェアの世界市場:現状分析と予測(2021年~2027年)
市場調査レポート
商品コード
1096522

脳モダリティおよびソフトウェアの世界市場:現状分析と予測(2021年~2027年)

Brain Modalities and Software Market: Current Analysis and Forecast (2021-2027)

出版日: | 発行: UnivDatos Market Insights Pvt Ltd | ページ情報: 英文 243 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.58円
脳モダリティおよびソフトウェアの世界市場:現状分析と予測(2021年~2027年)
出版日: 2022年05月01日
発行: UnivDatos Market Insights Pvt Ltd
ページ情報: 英文 243 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 目次
概要

世界の脳モダリティおよびソフトウェアの市場規模は、予測期間(2021年~2027年)中に約5%のCAGRで成長すると予測されています。

市場の成長は、神経疾患の発生率や有病率の上昇、神経変性疾患に対する意識の高まり、外傷性脳損傷の増加などに起因しています。

当レポートでは、世界の脳モダリティおよびソフトウェア市場について調査しており、市場の洞察、市場の動向、競合シナリオ、企業概要など、包括的な情報を提供しています。

目次

第1章 市場のイントロダクション

  • 市場の定義
  • 制限
  • ステークホルダー
  • レポートで使用される通貨

第2章 調査方法または仮定

  • 脳モダリティおよびソフトウェア市場の調査プロセス
  • 脳モダリティおよびソフトウェア市場の調査手法
  • 予測方法
  • 回答者のプロファイル
  • 脳モダリティおよびソフトウェア市場調査の主な目的

第3章 市場の要約

第4章 エグゼクティブサマリー

第5章 脳モダリティおよびソフトウェア市場におけるCOVID-19の影響

第6章 脳モダリティおよびソフトウェア市場の収益(10億米ドル)(2019年~2027年)

第7章 市場の洞察:オファリング別

  • 脳イメージングモダリティ
  • 脳分析ソフトウェア

第8章 市場の洞察:患者タイプ別

  • 成人
  • 小児および乳幼児

第9章 市場の洞察:アプリケーション別

  • 外傷性脳損傷(TBI)
  • 頭痛障害
  • てんかん
  • 睡眠障害
  • パーキンソン病
  • 脳卒中
  • ハンチントン病
  • 認知症
  • その他

第10章 市場の洞察:エンドユーザー別

  • 病院とクリニック
  • 神経内科センター
  • 外来手術センター
  • 診断センター

第11章 市場の洞察:地域別

  • 北米の脳モダリティおよびソフトウェア市場
    • 米国
    • カナダ
    • その他の北米
  • 欧州の脳モダリティおよびソフトウェア市場
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他の欧州
  • アジア太平洋の脳モダリティおよびソフトウェア市場
    • 中国
    • 日本
    • インド
    • その他のアジア太平洋
  • その他

第12章 脳モダリティおよびソフトウェア市場力学

  • 市場促進要因
  • 市場の課題
  • 影響分析

第13章 脳モダリティおよびソフトウェア市場の機会

第14章 脳モダリティおよびソフトウェア市場の動向

第15章 政策と規制状況

第16章 需要と供給側の分析

  • 需要側分析
  • 供給側分析

第17章 競合シナリオ

  • 競合情勢
    • ポーターのファイブフォース分析

第18章 会社概要

  • Vuno Co. Ltd.
  • Fujifilm Holdings Corporation
  • Imaging Biometrics LLC
  • A.I. Analysis Inc.
  • Aspect Imaging Ltd.
  • IXICO plc
  • Mint Labs Inc.
  • Medtronic plc
  • CAS Medical Systems Inc.
  • Dragerwerk AG & Co. KGaA.

第19章 免責事項

目次
Product Code: UMHE21842

Brain modalities and software market is expected to witness a CAGR of ~5% over the forecast period (2021-2027). brain modalities and software devices are used to monitor and diagnose neurological conditions by exploring the structure and function of the brain. This process involves the use of several brain modalities and software devices such as electroencephalography devices, intracranial pressure monitors, and magnetoencephalography to track brain functions. In addition, according to the World Health Organization (WHO), the global prevalence of epilepsy and multiple sclerosis was calculated at 50 million and 2.5 million respectively. These stats show the need for brain modalities and Software devices in the global healthcare industry today. The market offers a wide range of devices to treat abnormal brain activities and restore their functioning, depending on the case.

The growth of this market is driven owing to the rising incidence and prevalence of neurological disorders, rising awareness of neurodegenerative diseases, and growth in the number of traumatic brain injuries. For instance, According to World Health Organization (WHO), in September 2021 more than 55 million people live with dementia worldwide, and there are nearly 10 million new cases every year. Also, in 2019, globally, 50 million people were diagnosed with epilepsy. According to World Health Organization (WHO), nearly 80% population live in low- and middle-income countries.According to the world health organization (WHO), the ratio of death in the U.S. with epilepsy as the underlying cause from 2015 to 2020. the death ratio for epilepsy was 0.6 per 100,000 population, a slight increase from a rate of 0.4 in the year 2015.

Epilepsy is a general term used to describe a group of related neurological disorders characterized by recurrent seizures. Seizures among epileptics can vary in frequency and seriousness and can last a few seconds or a few minutes. Some of the most common seizure triggers among epileptics include bright flashing lights, stress, lack of sleep, illness or fever, and alcohol, caffeine, and other drugs. In most cases, the cause of epilepsy is unknown, but the disorder can result from stroke, brain injury, brain tumors, or serious illness. Approximately 1.1 percent of the population of the U.S. currently lives with epilepsy, with the disorder occurring equally among men and women.

Vuno Co. Ltd., Fujifilm Holdings Corporation, Imaging Biometrics LLC, A.I. Analysis Inc., Aspect Imaging Ltd., IXICO plc, Mint Labs Inc., Medtronic, CAS Medical Systems, Inc., Dragerwerk AG & Co. KGaA. are some of the prominent players operating in the brain modalities and software market. Several M&A's along with partnerships have been undertaken by these players to develop new and advanced products.

Insights Presented in the Report

Amongst by offering, the brain imaging modalities segment to hold significant share"

Based by offering, the brain modalities and software market is bifurcated into brain imaging modalities, and brain analysis software. Among these, the brain imaging modalities category held the largest share in the market. This is mainly due to the rising incidence of neurological, traumatic brain injuries, psychotic, and sleep disorders, the need for early diagnosis, and increasing patient awareness.

"Amongst by patient type, the traumatic brain injury (TBI) segment holds the major share"

Based on patient type, the market is categorized into adults, pediatrics & infants. Among these, the pediatrics & infants category is projected to witness significant growth during the forecast period. Some neurological conditions are inborn, caused by birthing mishaps, such as hemorrhage, asphyxia, hydrocephalus, a viral or bacterial infection contracted during pregnancy, delivery, or after birth, and use of alcohol or drugs during pregnancy. Furthermore, rising incidences of traumatic brain injuries is also a key factor driving the market.

"Amongst end-user, the diagnostic image centers segment holds the major share"

Based on end-users, the brain modalities and software devices market is segmented into hospitals & clinics, neurology centers, ambulatory surgery centers (ACS), and diagnostic image centers. The diagnostic image centers is expected to hold a dominant position during the forecast period. Brain modalities and software is a complex process, requiring expensive and advanced devices and equipment that are mainly found in diagnostic image centers. Additionally, brain modalities and software devices pose a considerable burden in terms of maintenance expenses on healthcare facilities, more than other end-users.

"North America signifies one of the largest markets of Brain Modalities and Software market"

For a better understanding of the market adoption, the report provides a detailed analysis of major regions and countries including North America (US, Canada, Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of APAC), and Rest of World. North America is expected to dominate the brain modalities and software market due to the growing incidence of neurological diseases coupled with rising expenditure on development of advance products and systems for treatment of various neurological and other diseases. However, Asia-Pacific is expected to experience the highest growth rate during the forecast period, due to the increase in the geriatric population.

Reasons to buy this report:

  • The study includes market sizing and forecasting analysis validated by authenticated key industry experts
  • The report presents a quick review of overall industry performance at one glance
  • The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments
  • Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry
  • The study comprehensively covers the market across different segments
  • Deep dive regional level analysis of the industry

Customization Options:

The brain modalities and software market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

TABLE OF CONTENTS

1 MARKET INTRODUCTION

  • 1.1. Market Definitions
  • 1.2. Limitation
  • 1.3. Stakeholders
  • 1.4. Currency used in Report

2 RESEARCH METHODOLOGY OR ASSUMPTION

  • 2.1. Research Process of the Brain Modalities & Software Market
  • 2.2. Research Methodology of the Brain Modalities & Software Market
  • 2.3. Forecasting Method
  • 2.4. Respondent Profile
  • 2.5. Main Objective of the Brain Modalities & Software Market Study

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 IMPACT OF COVID-19 ON THE BRAIN MODALITIES & SOFTWARE MARKET

6 BRAIN MODALITIES & SOFTWARE MARKET REVENUE (USD BN), 2019-2027F

7 MARKET INSIGHTS BY OFFERING

  • 7.1. Brain Imaging Modalities
  • 7.2. Brain Analysis Software

8 MARKET INSIGHTS BY PATIENT TYPE

  • 8.1. Adults
  • 8.2. Pediatrics & Infants

9 MARKET INSIGHTS BY APPLICATION

  • 9.1. Traumatic Brain Injury (TBI)
  • 9.2. Headache Disorders
  • 9.3. Epilepsy
  • 9.4. Sleep Disorders
  • 9.5. Parkinson's Disease
  • 9.6. Stroke
  • 9.7. Huntington's Disease
  • 9.8. Dementia
  • 9.9. Others

10 MARKET INSIGHTS BY END-USER

  • 10.1. Hospitals & Clinics
  • 10.2. Neurology Centers
  • 10.3. Ambulatory Surgery Centers
  • 10.4. Diagnostic Centers

11 MARKET INSIGHTS BY REGION

  • 11.1. North America Brain Modalities & Software Market
    • 11.1.1. U.S.
    • 11.1.2. Canada
    • 11.1.3. Rest of North America
  • 11.2. Europe Brain Modalities & Software Market
    • 11.2.1. Germany
    • 11.2.2. U.K.
    • 11.2.3. France
    • 11.2.4. Italy
    • 11.2.5. Spain
    • 11.2.6. Rest of Europe
  • 11.3. Asia-Pacific Brain Modalities & Software Market
    • 11.3.1. China
    • 11.3.2. Japan
    • 11.3.3. India
    • 11.3.4. Rest of Asia-Pacific
  • 11.4. Rest of World Brain Modalities & Software Market

12 BRAIN MODALITIES & SOFTWARE MARKET DYNAMICS

  • 12.1. Market Drivers
  • 12.2. Market Challenges
  • 12.3. Impact Analysis

13 BRAIN MODALITIES & SOFTWARE MARKET OPPORTUNITIES

14 BRAIN MODALITIES & SOFTWARE MARKET TRENDS

15 POLICY AND REGULATORY LANDSCAPE

16 DEMAND AND SUPPLY-SIDE ANALYSIS

  • 16.1. Demand Side Analysis
  • 16.2. Supply Side Analysis

17 COMPETITIVE SCENARIO

  • 17.1. Competitive Landscape
    • 17.1.1. Porter's Five Forces Analysis

18 COMPANY PROFILED

  • 18.1. Vuno Co. Ltd.
  • 18.2. Fujifilm Holdings Corporation
  • 18.3. Imaging Biometrics LLC
  • 18.4. A.I. Analysis Inc.
  • 18.5. Aspect Imaging Ltd.
  • 18.6. IXICO plc
  • 18.7. Mint Labs Inc.
  • 18.8. Medtronic plc
  • 18.9. CAS Medical Systems Inc.
  • 18.10. Dragerwerk AG & Co. KGaA.

19 DISCLAIMER